Bart is Head of the Department of Ophthalmology, and Staff Member at the Center for
Medical Genetics at the Ghent University Hospital.

He is Full Professor of Ophthalmology and Ophthalmic Genetics at the Department of Head & Skin at Ghent University. Between August 2013 and March 2020, Bart also was a part-time (20%) attending physician at the Division of Ophthalmology & Center for Cellular & Molecular Therapeutics at Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Bart Leroy is an ophthalmologist and clinical geneticist specialised in, and passionate about
inherited eye disorders. In collaboration with the teams at the University of Pennsylvania and
Children’s Hospital of Philadelphia, Philadelphia, PA, USA, and Ghent University (Hospital),
Ghent, Belgium, Bart is involved in deep phenotyping and genotyping studies, and gene
therapy projects for inherited retinal blindness. He was part of the team led by Profs J
Bennett, AM Maguire & K High that helped bring Luxturna to market with in the USA & EU.

He is Senior Clinical Investigator of the Research Foundation Flanders (Belgium) since 2010
until 2025. He is (co-)recipient of 32 scientific grants and prizes. Bart is board member of
several professional organisations, including ISGEDR (Secretary-General), ERN-EYE (WG1
Retinal Diseases Co-Lead), EURETINA (Board Member for IRDs) and SGOF. He leads several
multi-stakeholder efforts to increase awareness of IRDs through several channels.